Vulval tumours involve abnormal growths on the external female genitalia, which include the labia majora, labia minora, clitoris, and perineal glands. While relatively rare compared to other gynaecological cancers, these growths demand careful clinical attention because they significantly affect both physical comfort and psychological well-being. The vulva features rich vascular and lymphatic networks, meaning malignant cells can metastasize to inguinal and femoral lymph nodes relatively early in the disease process. Understanding this local anatomy helps nurses anticipate why patients often present with localized swelling, persistent ulcers, or regional lymphadenopathy during initial assessments.
Tumours of the vulva divide broadly into benign growths and malignant neoplasms. Benign lesions do not invade surrounding tissues or spread to distant sites, whereas malignant tumours are locally invasive and potentially metastatic.
The development of vulval malignancies stems from a combination of viral, inflammatory, and lifestyle factors. Persistent infection with high-risk human papillomavirus strains, particularly HPV 16, strongly correlates with younger women developing vulvar intraepithelial neoplasia and subsequent squamous cell carcinoma. Conversely, older women often develop non-HPV-related vulval cancer through chronic inflammatory dermatoses like lichen sclerosus. Tobacco smoking also acts as an independent risk factor by suppressing local immune responses in the genital mucosa.
Patients with vulval tumours often delay seeking medical care due to embarrassment or by mistaking symptoms for common infections or dermatitis. A thorough nursing history and physical inspection are critical for early detection.
Confirming a diagnosis of a vulval tumour requires direct visual inspection and tissue sampling. Nurses prepare the patient for clinical examination, which may involve colposcopy to inspect suspicious areas under magnification with acetic acid or iodine stains. A punch biopsy is performed under local anaesthesia to obtain definitive histological confirmation of the tissue type and grading. Imaging studies like pelvic MRI or CT scans are subsequently ordered to assess the depth of invasion and check for lymph node involvement.
Treatment strategies depend heavily on the stage of the tumour, its histological type, and the patient's overall health status. Surgery remains the primary treatment modality for most localized vulval cancers, ranging from wide local excision to radical vulvectomy with inguinal lymph node dissection. Radiation therapy and chemotherapy may be used as neoadjuvant treatments to shrink large tumours before surgery, or as definitive therapy for patients who cannot tolerate surgical procedures.
Nursing care for patients with vulval tumours addresses both physical wound healing and profound psychological distress. Postoperative care focuses on meticulous perineal hygiene, preventing wound breakdown, and monitoring for signs of infection or lymphoedema in the lower limbs. Nurses must also create a supportive, non-judgmental environment because surgeries in the genital region deeply impact body image, sexual health, and self-esteem. Providing empathetic counselling and referrals to support groups helps patients navigate these sensitive challenges.